Wedbush Securities’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,000
Closed -$14K 1311
2024
Q1
$14K Hold
20,000
﹤0.01% 1227
2023
Q4
$17K Hold
20,000
﹤0.01% 1078
2023
Q3
$27K Buy
+20,000
New +$43.3K ﹤0.01% 1045

Other funds holding VAXX

Wedbush Securities's VAXX Position: Q2 2024 in Review

Wedbush Securities sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 20,000 shares — an estimated $14K sold.

Wedbush Securities first reported a position in VAXX in Q3 2023 and held it in 3 quarters. The position peaked at $27K in Q3 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Wedbush Securities reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wedbush Securities sold 20,000 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $14K.
  • Wedbush Securities first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2023 and held it in 3 quarters.
  • Wedbush Securities's Vaxxinity, Inc. Class A Common Stock position peaked at $27K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Wedbush Securities's 13F filing for Q2 2024, filed 7 Aug 2024.